PT1169019E - Formulacao farmaceutica em aerossol - Google Patents

Formulacao farmaceutica em aerossol

Info

Publication number
PT1169019E
PT1169019E PT00925450T PT00925450T PT1169019E PT 1169019 E PT1169019 E PT 1169019E PT 00925450 T PT00925450 T PT 00925450T PT 00925450 T PT00925450 T PT 00925450T PT 1169019 E PT1169019 E PT 1169019E
Authority
PT
Portugal
Prior art keywords
formulations
aerosol
relates
pharmaceutical formula
novel
Prior art date
Application number
PT00925450T
Other languages
English (en)
Inventor
Cecile Isabelle Bonvoisin
Christophe Laroche
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9921289.6A external-priority patent/GB9921289D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT1169019E publication Critical patent/PT1169019E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT00925450T 1999-04-14 2000-04-13 Formulacao farmaceutica em aerossol PT1169019E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BH12699 1999-04-14
GBGB9921289.6A GB9921289D0 (en) 1999-09-10 1999-09-10 Pharmaceutical aerosol formulation

Publications (1)

Publication Number Publication Date
PT1169019E true PT1169019E (pt) 2003-07-31

Family

ID=25663377

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00925450T PT1169019E (pt) 1999-04-14 2000-04-13 Formulacao farmaceutica em aerossol

Country Status (10)

Country Link
US (1) US7090831B1 (pt)
EP (1) EP1169019B1 (pt)
JP (1) JP2002541183A (pt)
AT (1) ATE233084T1 (pt)
AU (1) AU4417500A (pt)
DE (1) DE60001492T2 (pt)
DK (1) DK1169019T3 (pt)
ES (1) ES2193069T3 (pt)
PT (1) PT1169019E (pt)
WO (1) WO2000061108A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080064613A1 (en) * 2006-09-11 2008-03-13 M-I Llc Dispersant coated weighting agents
EP1337239B2 (en) * 2000-11-30 2015-11-25 Vectura Limited Particles for use in a pharmaceutical composition
PT1920763E (pt) 2000-11-30 2014-06-25 Vectura Ltd Composições farmacêuticas para inalação
IL156308A0 (en) * 2000-12-22 2004-01-04 Glaxo Group Ltd Metered dose inhaler for salmeterol xinafoate
WO2003024452A1 (de) * 2001-09-14 2003-03-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue arzneimittel zur inhalation
AU2003259910A1 (en) * 2002-08-14 2004-03-03 E.I. Du Pont De Nemours And Company Process for coating a pharmaceutical particle
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US20050244503A1 (en) * 2003-05-19 2005-11-03 Rabinow Barrett E Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents
GB0321607D0 (en) 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
WO2005051511A1 (ja) * 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
JP2008510015A (ja) 2004-08-16 2008-04-03 セラヴァンス， インコーポレーテッド β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物
EP2213165A1 (en) * 2007-11-27 2010-08-04 Erc Technology Inc. Novel compositions containing ozonized surfactant
EP3620154A1 (en) 2009-02-06 2020-03-11 University Of Southern California Therapeutic compositions comprising monoterpenes
PL3111926T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CN102470130B (zh) 2009-07-15 2013-09-04 施万制药 联苯化合物的结晶游离碱形式
BR112012022209A2 (pt) 2010-03-03 2017-06-06 Neonc Tech Inc composições farmacêuticas compreendendo monoterpenos
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
BR112013004698B1 (pt) 2010-08-27 2022-03-22 Neonc Technologies Inc. Composições farmacêuticas compreendendo derivados de poh
DK2651864T3 (en) 2010-12-17 2016-09-05 Neonc Tech Inc Methods and devices for use of isoperillylalkohol
EP2765994B1 (en) 2011-10-11 2018-12-05 Chiesi Farmaceutici S.p.A. Crystalline microparticles of a beta-agonist coated with a fatty acid
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
PL2968312T3 (pl) 2013-03-15 2018-08-31 Verona Pharma Plc Kombinacja leków
DE102013021718B4 (de) * 2013-12-20 2017-03-02 Gerresheimer Regensburg Gmbh Kapsel zur Verwendung als Reservoir für eine pharmazeutische, vorzugsweise pulverförmige Zubereitung in einem Inhalator sowie Inhalator dafür
HUE048020T2 (hu) 2014-05-12 2020-05-28 Verona Pharma Plc Új kezelés
CN112142749A (zh) 2015-02-12 2020-12-29 NeOnc技术股份有限公司 紫苏醇衍生物、药物组合物及其用途
US10858305B2 (en) 2016-11-30 2020-12-08 Neonc Technologies, Inc. Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer
CA3225993A1 (en) 2018-02-08 2019-08-15 University Of Southern California The use of monoterpene, sesquiterpene, or their derivatives to permeabilize the blood brain barrier

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535531A (en) * 1976-10-15 1978-12-13 Warmer & Co Ltd W Pharmaceutical compositions
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
AU612591B2 (en) 1986-08-11 1991-07-18 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
JPH05507090A (ja) 1990-05-08 1993-10-14 リポサーム　テクノロジー　インコーポレイテッド 直接噴霧乾燥された薬剤／脂質粉末組成物
GB9024366D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
GB9024365D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
GB9026005D0 (en) 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
ATE171865T1 (de) 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
SG42375A1 (en) 1991-12-31 2001-04-17 Solvay Medicinal aerosol formulation
MX9304585A (es) 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
EP0655237A1 (de) 1993-11-27 1995-05-31 Hoechst Aktiengesellschaft Medizinische Aerosolformulierung
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
JPH08151322A (ja) * 1994-09-30 1996-06-11 Takeda Chem Ind Ltd 経口徐放剤
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9606188D0 (en) 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
WO1998029098A1 (en) 1996-12-31 1998-07-09 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
CN1145478C (zh) * 1998-04-18 2004-04-14 葛兰素集团有限公司 药用气溶胶制剂
GB9828721D0 (en) 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process

Also Published As

Publication number Publication date
EP1169019B1 (en) 2003-02-26
DE60001492T2 (de) 2003-12-18
JP2002541183A (ja) 2002-12-03
ES2193069T3 (es) 2003-11-01
DK1169019T3 (da) 2003-06-02
EP1169019A1 (en) 2002-01-09
AU4417500A (en) 2000-11-14
WO2000061108A1 (en) 2000-10-19
DE60001492D1 (de) 2003-04-03
US7090831B1 (en) 2006-08-15
ATE233084T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
PT1169019E (pt) Formulacao farmaceutica em aerossol
EA200000956A1 (ru) Фармацевтический аэрозольный препарат
ES2178817T3 (es) Formulaciones medicinales de aerosol.
DE60123793D1 (de) Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend
IT1255040B (it) Forma di ciclosporina adatta alla somministrazione per via polmonare eprocedimento di preparazione.
ZA200100408B (en) Medicinal aerosol formulations.
HUP0000795A2 (hu) Budeszonidot tartalmazó, aeroszol formájú gyógyszerkészítmény
DE60308997D1 (de) Formulierungen zur inhalation
CA2335065A1 (en) Pharmaceutical formulations for aerosols with two or more active substances
ATE291898T1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
HUP0103925A2 (hu) Formoterolt tartalmazó, stabilan tárolható hatóanyag-koncentrátum
HUP0100865A2 (hu) Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69102161T2 (de) Gemische von Dimethyläther und 1,1,1,2-Tetrafluoräthan und deren Verwendungen.
WO2002076176A3 (en) Mixtures containing 1,1,1,3,3-pentafluoropropane and 1,1,1,3,3-pentafluorobutane
EP1523976A3 (en) Pharmaceutical formulations of salmeterol